Target Price | €48.34 |
Price | €45.17 |
Potential | 7.03% |
Number of Estimates | 17 |
17 Analysts have issued a price target Qiagen 2026 . The average Qiagen target price is €48.34. This is 7.03% higher than the current stock price. The highest price target is €52.44 16.10% , the lowest is €43.00 4.79% . | |
A rating was issued by 21 analysts: 12 Analysts recommend Qiagen to buy, 9 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Qiagen stock has an average upside potential 2026 of 7.03% . Most analysts recommend the Qiagen stock at Purchase. |
18 Analysts have issued a sales forecast Qiagen 2024 . The average Qiagen sales estimate is €1.9b . This is 3.51% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €1.9b 6.40% , the lowest is €1.8b 0.86% .
This results in the following potential growth metrics:
2023 | €1.8b | 10.79% |
---|---|---|
2024 | €1.9b | 3.29% |
2025 | €2.0b | 5.02% |
2026 | €2.1b | 6.60% |
2027 | €2.3b | 8.19% |
2028 | €2.5b | 7.88% |
17 Analysts have issued an Qiagen EBITDA forecast 2024. The average Qiagen EBITDA estimate is €644m . This is 2.51% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €758m 20.62% , the lowest is €285m 54.70% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | €602m | 19.40% |
---|---|---|
2024 | €644m | 7.06% |
2025 | €714m | 10.85% |
2026 | €782m | 9.56% |
2027 | €844m | 7.88% |
2028 | €915m | 8.39% |
2023 | 33.10% | 9.65% |
---|---|---|
2024 | 34.31% | 3.64% |
2025 | 36.22% | 5.57% |
2026 | 37.22% | 2.76% |
2027 | 37.12% | 0.27% |
2028 | 37.29% | 0.46% |
7 Qiagen Analysts have issued a net profit forecast 2024. The average Qiagen net profit estimate is €93.8m . This is 17.17% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €107m 33.60% , the lowest is €77.8m 2.79% .
This results in the following potential growth metrics and future Net Margins:
2023 | €313m | 21.67% |
---|---|---|
2024 | €93.8m | 70.08% |
2025 | €409m | 336.26% |
2026 | €472m | 15.39% |
2027 | €531m | 12.44% |
2028 | €579m | 9.02% |
2023 | 17.24% | 12.20% |
---|---|---|
2024 | 4.99% | 71.05% |
2025 | 20.74% | 315.63% |
2026 | 22.45% | 8.24% |
2027 | 23.33% | 3.92% |
2028 | 23.58% | 1.07% |
7 Analysts have issued a Qiagen forecast for earnings per share. The average Qiagen <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is €0.42 . This is 16.67% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is €0.48 33.33% , the lowest is €0.35 2.78% .
This results in the following potential growth metrics and future valuations:
2023 | €1.41 | 21.67% |
---|---|---|
2024 | €0.42 | 70.21% |
2025 | €1.84 | 338.10% |
2026 | €2.12 | 15.22% |
2027 | €2.39 | 12.74% |
2028 | €2.60 | 8.79% |
Current | 123.28 | 307.00% |
---|---|---|
2024 | 106.53 | 13.59% |
2025 | 24.42 | 77.08% |
2026 | 21.16 | 13.35% |
2027 | 18.82 | 11.06% |
2028 | 17.26 | 8.29% |
Based on analysts' sales estimates for 2024, the Qiagen stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 5.52 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 5.31 .
This results in the following potential growth metrics and future valuations:
Current | 5.71 | 6.93% |
---|---|---|
2024 | 5.52 | 3.35% |
2025 | 5.26 | 4.77% |
2026 | 4.93 | 6.20% |
2027 | 4.56 | 7.57% |
2028 | 4.22 | 7.30% |
Current | 5.50 | 7.69% |
---|---|---|
2024 | 5.31 | 3.39% |
2025 | 5.06 | 4.78% |
2026 | 4.74 | 6.20% |
2027 | 4.38 | 7.57% |
2028 | 4.06 | 7.30% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.